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Abstract
We present a practical protocol for the assignment of
values to serum proteins in a Target Material using a
Reference Material. This protocol is based on the
model of Direct Value Transfer between serum matri-
ces and is intended to improve the value assignment
of commercial calibrators using the Reference Mate-
rial CRM 470 (now labeled ERM-DA 470) or similar
The exclusive  for all languages and countries is vested1)
in the International Federation of Clinical Chemistry and Lab-
oratory Medicine.
IFCC Sections printed in J. Clin. Chem. Clin. Biochem. are2)
listed in the Cumulative Index, which appeared in connection
with the contents of this journal in Volume 27, 1989 and
since 1991 have been printed in (Eur.) J. Clin. Chem. Clin.
Biochem.
IFCC 1991/1 Vol. 29, 435–457
IFCC 1991/2 Vol. 29, 531–535
IFCC 1991/3 Vol. 29, 577–586
IFCC 1991/4 Vol. 29, 767–772
IFCC 1992/1 Vol. 30, 901–905
IFCC 1994/1 Vol. 32, 639–655
IFCC 1995/1 Vol. 33, 247–253
IFCC 1995/2 Vol. 33, 399–404
IFCC 1995/3 Vol. 33, 623–625
IFCC 1995/4 Vol. 33, 627–636
IFCC 1995/5 Vol. 33, 637–660
IFCC 1997/1 Vol. 35, 317–344
IFCC 1997/2 Vol. 35, 345–349
IFCC 1997/3 Vol. 35, 805–831
IFCC 1997/4 Vol. 35, 833–843
For IFCC sections printed in Clin. Chem. Lab. Med. since
1998, please visit the link http://degruyter.com/journals/
extenza, where they are freely accessible.
*Corresponding author: S. Blirup-Jensen, DVM, PhD,
Department of Clinical Chemistry, Lund University Hospital,
221 85 Lund, Sweden
Phone: q46-46-173465, Fax: q46-46-130064,
E-mail: Soren.Blirup@med.lu.se
Received for publication June 25, 2008;
previously published online August 29, 2008
reference materials. The procedure describes the gen-
eral as well as the practical principles involved in the
value assignment (with examples). The practical
transfer protocol is based on multiple assays of 6 dilu-
tions of the Reference Material and 6 dilutions of the
Target Material. The transfer protocol requires several
measurements a day repeated on several days, an
important prerequisite being that all reconstitutions
and dilutions are controlled by weighing thus reduc-
ing uncertainty in the transfer. In open systems that
allow the use of the Reference Material as calibrator
and the Target Material as samples, the proportion-
ality of the two materials (the presence or absence of
matrix effects) can now be directly assessed by eval-
uating a single regression plot. If no matrix effects are
found, the regression line will pass through zero with
a slope equal to the ratio of the concentrations of the
two materials. In closed systems, the dedicated com-
mercial calibrator has to be used as such; the Refer-
ence Material and the Target Material are now
assayed as samples against this calibrator. Two
regression plots are therefore obtained; if no matrix
effects are present among the two materials and the
calibrator, both the Reference and Target Materials
will show zero intercepts, and the ratio of the two
slopes will equal the ratio of the concentrations.
Clin Chem Lab Med 2008;46:1470–9.
Keywords: protein standardization; transfer protocol;
value assignment; value transfer.
Abbreviations: C’RsStated analyte concentration in the Ref-
erence Material; CRsActual analyte concentration in the Ref-
erence Material after reconstitution; CTsUnknown analyte
concentration in the Target Material; FR(1–6)sRelative con-
centration factors 1–6 of the Reference Material obtained by
interpolation; FT1sPredilution factor 1 for the Target Mate-
rial; FT2sDilution factor 2 for the Target Material; MXsMass
of x (where x can be: reconstituent intended, water, Refer-
ence Material, Dilution buffer or Target Material); RsCorrec-
tion factor for the Reference Material after reconstitution;
TsCorrection factor for the Target Material after reconsti-
tution; UYsUncertainty of Y (where Y can be: Total, Refer-
ence Material or Transfer procedure); asIntercept of the
linear regression line; bsSlope of the linear regression line.
Introduction
When the international Reference Preparation for
Human Serum Proteins (CRM 470) was prepared (1),
procedures and protocols were developed for the
transfer of values to this material (2). This new
approach for the assignment of values to serum pro-
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teins in a Target Material using a Reference Prepara-
tion was developed and published by Blirup-Jensen,
Johnson and Larsen (3).
The introduction of the Certified Reference Material
(CRM 470, now referred to as ERM-DA 470) has defi-
nitely improved the worldwide results of quantitative
serum protein determinations as seen from the vari-
ous national quality assurance programs (4–7).
However, differences as large as 15% among manu-
facturers’ assays persist for some proteins. Several
factors may contribute to this, including (among
others) different antiserum reactivities, assay meth-
ods, genetically determined structural variation in the
proteins themselves, inadequate methods of value
transfer, and matrix differences among the materials.
In a given case, any or all of these may be operable,
and the results may be additive. The first three of
these are difficult if not impossible to control.
In our first publication (3), we focused on a general
discussion of the value transfer principles and pre-
sented the necessary mathematical equations. How-
ever, following the development we have realized the
necessity – also encouraged by many users – to pro-
duce a more practical (easy to follow) protocol for the
value transfer. Therefore, in an attempt to aid manu-
facturers in transferring values accurately and thereby
to reduce the among-manufacturer bias in serum pro-
tein assays, the authors have been encouraged to pre-
pare a protocol with simple mathematical calculations
and some practical recommendations to be used
when values are to be transferred from certified ref-
erence materials to manufacturers’ working calibra-
tors (master calibrators) and then to their commercial
calibrators and controls.
The methods used today for serum protein assays
are based on immunochemical principles utilizing the
specific reaction between an antigen and its corre-
sponding antibody.
Common to all quantitative methods is the basic
principle of calibrating the assay, i.e., recording the
signals from different dilutions of a calibrator with
known concentration of the actual protein. Once the
instrument has been calibrated, unknown patient
samples can be assayed and quantified by interpola-
tion on the established standard curve.
As part of the daily routine, the clinical laboratory
may perform a considerable number of specific quan-
titative protein determinations. In order to do this,
reliable assays are required. During the last decade,
the original gel precipitation techniques have increas-
ingly been replaced by fast and automated optical
detection systems, which take advantage of the fast
and specific reaction between an antigen and the
corresponding antibody in a liquid phase. Most of
these systems are based on immunoturbidimetry and
immunonephelometry, measuring the light absorbed
or scattered by the antigen-antibody complexes
formed in free solution. Earlier studies (8) have shown
that, due to the fast reaction between the antigen and
the antibody, optimal programming of the instrument
is a very important factor for obtaining reliable and
reproducible results.
The different reagents also play an important role.
Slight variations in the specificity and titer of the anti-
body may cause erroneous results. Likewise, the com-
position of the reaction buffer, the pH and the
polymer concentration may influence the accuracy of
the final result. This has led to the prerequisite of
Method Standardization (8).
Provided that the instrument is programmed
correctly and the reagents used are of sufficient qual-
ity, the concentration in a patient sample will be
expressed in relation to the value of the calibrator. It
is therefore of the highest importance that the cali-
brator be value assigned correctly.
General principles
The goal of the value transfer is to assign concentra-
tions to selected proteins in a Target Material using
an International Reference Preparation. In order to do
this, Transfer Methods must be selected and Transfer
Protocols developed.
The Reference Material (earlier also referred to as
the Reference Preparation) is defined as the protein
preparation with known concentration values (e.g.,
assigned using a consensus procedure). In this exam-
ple of value transfer, the Reference Material CRM 470
(now referred to as ERM-DA 470) is used. The prep-
aration and value assignment of this material were
documented in 1993 (1). Since the original Reference
Material is gradually coming to an end, a replacement
material with similar values is currently being made
by the Institute for Reference Materials and Methods
(IRMM), Geel, Belgium, and should be available dur-
ing 2008.
The Target Material is defined as the serum protein
matrix material (e.g., a manufacturer’s calibrator) with
unknown concentration values.
The Transfer Method should be a well established
and a recognized routine method, such as turbidi-
metry, nephelometry or single radial immunodiffusion.
However, slight variations in the assay conditions,
in the programming of the instruments or in the re-
agents may lead to different results. This has led to
the prerequisite of Method Standardization (8).
To minimize all of these factors, an accurate Trans-
fer Protocol with detailed instructions, dilution
schemes, parameter settings, etc., should also be
used.
Finally data reduction and proper statistical evalu-
ation are required for certification of the values
obtained.
The practical protocol for value transfer outlined in
this paper is an attempt to describe in detail how a
value assignment can be conducted in order to mini-
mize the variability and differences on the transfer of
values to manufacturers’ calibration and control
materials for serum proteins.
To illustrate the various aspects of the practical pro-
tocol, a real example is presented with a detailed
description of each step of the procedure, in which
the concentration value of human IgG is value
assigned to a Target Material (a human serum
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matrixed material) from a Reference Material (CRM
470 or now ERM-DA 470).
General procedure for the direct value
assignment (the Transfer Protocol)
The Transfer Protocol is based on multiple-point val-
ue assignment obtained by several measurements a
day repeated on several days.
All volumes for reconstitution and dilutions must be
controlled by weight using a balance with 0.0001 g
precision.
Reference Material: 6 different dilutions used as
standards for the calibration
curve and covering the actual
measuring range.
Target Material: 6 different dilutions distributed
within the measuring range
and placed as samples in 2
positions.
Control: 1 special dilution of the Refer-
ence Material in the higher end
of the measuring range and
placed as a sample in 2
positions.
Each day, a new set of dilutions is prepared and 3
calibrations including determinations of samples and
controls are carried out.
This procedure for 1 day is repeated for 4 days thus
giving:
Calibration curves: 6 different dilutions of the Ref-
erence Material used as stan-
dards repeated 3 times each
day over 4 dayss6=3=4s72
determinations.
Samples: 6 different dilutions of the Tar-
get Material analyzed in dupli-
cate 3 times a day in 4 dayss
6=2=3=4s144
determinations.
Controls: 1 special dilution of the Refer-
ence Material analyzed in dup-
licate 3 times a day in 4 dayss
2=3=4s24 determinations.
Materials
The value assignment can be performed in any opti-
mized and validated immunochemical system. It is
highly recommended to use the appropriate setup for
each specific instrument. In the example described in
this paper, the following reagents and instruments
were used:
• Reference Material: CRM 470 91/06 19 (IRMM,
Geel, Belgium).
• Target Material: Human Serum Protein Calibrator
X 908 (DAKO A/S, Copenhagen, Denmark).
• Reaction Buffer: S 2007 (DAKO A/S).
• Dilution Buffer: S 2005 (DAKO A/S).
• Saline Solution: 0.1 M NaCl, 15 mM Na-azide.
• Distilled or dematerialized water.
• Antibody: Rabbit anti-human IgG Q 0331 (DAKO
A/S).
• Turbidimeter: Cobas Fara II (F. Hoffmann-La Roche
Ltd., Basel, Switzerland).
• Balance: Sartorius, MC 410 S, Sartorius, Germany.
Practical procedure for the direct value assignment
Setup for 1 day For the following example, Day 4
from a real value transfer of human IgG has been
chosen.
Registration:
1. The following are documented on a special regis-
tration form:
a. The specific serum protein to be value assigned
– in this example human IgG.
b. The date for the first run.
c. The operator.
d. The instrument (Name, Producer, Model and
Lab. Instr. No.).
e. The Reference Material (Name, Producer, Code
No., Lot. No. and the concentration of the cho-
sen protein plus the uncertainty), e.g., ERM-DA
470 (CRM 470), IRMM, Lot no. 91/06 19, IgG
conc. 9.68 g/L, uncertainty 0.10 g/L.
f. The Target Material (Name, Producer, Code No.,
Lot. No.).
g. Reaction Buffer (Name, Producer, Code No., Lot.
No.).
h. Antibody (Name, Producer, Code No., Lot. No.).
i. Dilution Buffer for Standards (Name, Producer,
Code No., Lot. No.).
j. Dilution Buffer for Samples (Name, Producer,
Code No., Lot. No.).
k. Saline for Predilution (Name, Producer, Code
No., Lot. No.).
Pre-preparation:
2. Frozen material is thawed at 378C the afternoon
before the day of the measurements. After thaw-
ing, it is left next to the balance (at room temper-
ature) overnight.
3. Freeze-dried material is reconstituted the afternoon
before the day of the measurements and according
to the product insert. If no product insert is availa-
ble, this general recommendation may be used:
a. Leave the vial at room temperature for at least
2 h before beginning.
b. Tap the vial gently on the surface of the table
assuring that all material has settled onto the
bottom of the vial.
c. Remove the metal seal or screw cap.
d. Weigh the vial together with the rubber stopper
and record the weight.
e. Lift the rubber stopper with care until air is
allowed to enter and the groove in the rubber
stopper becomes accessible.
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Table 4 Human IgG – actual dilution scheme of the Reference Material.
Std. 1 Std. 2 Std. 3 Std. 4 Std. 5 Std. 6
Dilution buffer, g 0.7025 0.9025 1.1967 0.3500 0.6002 0.4985
Reference Material, g 0.0999 0.0993 0.0997 0.3935 (Std. 2) 0.5935 (Std. 3) 0.3922 (Std. 5)
Dilution factor 0.1245 0.0991 0.0769 0.5293 0.4972 0.4403
Predilution factor 1.0000 1.0000 1.0000 0.0991 0.0769 0.0382
Relative concentration, % 12.4501 9.9122 7.6905 5.2461 3.8237 1.6837
Table 3 Human IgG – intended dilution scheme of the Reference Material.
Std. 1 Std. 2 Std. 3 Std. 4 Std. 5 Std. 6
Dilution buffer, g 0.7000 0.9000 1.2000 0.3500 0.6000 0.5000
Reference Material, g 0.1000 0.1000 0.1000 0.4000 (Std. 2) 0.6000 (Std. 3) 0.4000 (Std. 5)
Dilution factor 0.1250 0.1000 0.0769 0.5333 0.5000 0.4444
Predilution factor 1.0000 1.0000 1.0000 0.1000 0.0769 0.0384
Relative concentration, % 12.5000 10.0000 7.6923 5.3333 3.8450 1.7087





Correction factor, T 1.00000





Correction factor, R 1.005025
f. With a precision pipette add 1000 mL (or other
specified volume) of distilled water and press
the rubber stopper back into place.
g. Reweigh the vial and record the weight.
h. Leave the vial at room temperature for approx-
imately 1 h.
i. Now carefully invert it several times (do not
shake it!) during the following hour.
j. Leave the vial next to the balance overnight.
Since the Reference Preparation (CRM 470) is
freeze-dried, the material is reconstituted as
described above. The actual weighing results are
illustrated in Table 1.
If the IgG value from the package insert is stated to
be 9.68 g/L (C’R) when reconstituted with 1.0000 mL
water, the actual value (CR) is now:
C’ $M 9.68=1.0000R Recon.
C s s s9.729 g/LR
M 0.9950water
where M is the mass of the reconstituent intended as
well as actual. A correction factor RsMRecon/MWater
could also be used directly, giving: CRsC’R$R.
If the Target Material must be reconstituted, a sim-
ilar procedure is followed and Table 2 is used. How-
ever, in this example the Target Material is already a
liquid serum, so reconstitution and weighing is not
needed.
Calibration standards:
4. 6 different dilutions are prepared from the recon-
stituted Reference Material. They should serve as
standards for the calibration curve and should
cover the actual measuring range. If the concen-
tration of the chosen protein is very high, a pre-
dilution of the Reference Material may be
required before the 6 standards are made. For
IgG, this is not necessary and the 6 standards are
prepared according to Table 3.
An example of the actual weighing results is illus-
trated in Table 4.
The relative concentrations in % for Std. 2 and
Std. 4 are calculated as:
M $100 0.993=100R
Rel. conc. (Std. 2)5 s
M HM 0.0993q0.9025R Dil
s9.9122%
M $Std. 2 0.3935=9.9122R
Rel. conc. (Std. 4)5 s
M HM 0.3935q0.3500R Dil
s5.2461%
To avoid pipetting very small volumes, Std. 4, Std.
5 and Std. 6 are prepared from Std. 2, Std. 3 and Std.
5, respectively. In total, 500 mL of each of the different
dilutions is transferred to a separate calibrator cup
and placed on the instrument in 6 consecutive cali-
brator positions according to the instruction manual
for the specific instrument. The relative concentration
values in % are entered into the appropriate calibra-
tion software window.
It is preferable to prepare all standards manually by
weighing all volumes as described. However, for
some instruments this is not possible, because the
instrument automatically prepares the 6 different
standards (dilutions) from the single calibrator.
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Table 5 Actual dilution of Control Sample.
Reference Material
Weight of Reference Material, g 0.0997
Weight of Dilution Buffer, g 1.0060
Dilution factor 0.0902
Relative concentration, % 9.0169
Table 8 Human IgG – actual sample dilution scheme of the prediluted Target Material.
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6
Dilution buffer, g 0.0000 0.1005 0.2012 0.4063 0.6025 0.7513
Target material, g 1.0000 0.8885 0.7918 0.5897 0.3979 0.2465
Total weight, g 1.0000 0.9890 0.9930 0.9960 1.0004 0.9978
Dilution factor, FT2 1.0000 0.8984 0.7974 0.5921 0.3977 0.2470
Predilution factor, FT1 0.091177 0.091177 0.091177 0.091177 0.091177 0.091177
Relative concentration, % 9.1177 8.1912 7.2703 5.3983 3.6265 2.2525
Table 7 Human IgG – intended sample dilution scheme of the prediluted Target Material.
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6
Dilution buffer, g 0 0.1000 0.2000 0.4000 0.6000 0.7500
Target material, g 1.0000 0.9000 0.8000 0.6000 0.4000 0.2500
Total Weight, g 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000
Dilution factor, FT2 1.0000 0.9000 0.8000 0.6000 0.4000 0.2500
Predilution factor, FT1 0.09090 0.09090 0.09090 0.09090 0.09090 0.09090
Relative concentration, % 9.0909 8.1818 7.2727 5.4545 3.6363 2.2727
Table 6 Actual predilution of Target Material.
Target Material
Weight of Target Material, g 0.3989
Weight of saline, g 3.9761
Total Weight, g 4.3750
Predilution factor, FT1 0.091177
Control sample:
5. The Control Sample is made as a special dilution
of the Reference Material (Table 5). It serves as a
curve control and should therefore be made so it
falls within the calibration curve. Weigh, e.g.,
0.1000 g reference serumq1.000 g Dilution buffer
and mix.
In total, 500 mL of the control is transferred to each
of two sample cups and placed on the instrument in
2 positions.
Sample preparation:
6. If the Target Material is frozen or freeze-dried, it
should be thawed or reconstituted as described
under the section Pre-preparation. This could sim-
ilarly give rise to a Correction Factor (T).
6 different dilutions are prepared from the (recon-
stituted) Target Material. They should serve as sam-
ples and should all be made so their concentrations
fall within the calibration curve. A trial run may be
necessary to establish an approximate concentration
of the protein in the Target Material.
For human IgG, a predilution of the Target Material
is recommended. The intended predilution is
(1q10s11= or 0.09090): 0.4000 g Target Materialq
4.0000 g dilution buffer. The actual predilution is illus-
trated in Table 6.
6 different dilutions are now prepared from the pre-
diluted Target Material according to Table 7.
An example of the actual weighing results of the 6
samples is illustrated in Table 8.
The dilution factor FT2 for Sample 3 is calculated
as:
M 0.7918T
F 2 (3)s s s0.7974T
(M HM ) 0.7918q0.2012T Dil
The relative concentration in % for Sample 3 is cal-
culated as:
M $100$F 1T T
Rel. conc. (Sample 3) s





The relative concentration in % of the Target Mate-
rial is useful to verify that the dilutions fall within the
measuring range of the calibration curve (prepared
from the Reference Material). However, for further
calculation the dilution factors FT2 (1–6) are used as
X-values representing the exact concentrations of IgG
in the samples (prepared from the Target Material).
500 mL of each of the different dilutions is trans-
ferred to each of two sample cups and placed on the
instrument as samples in 12 (2=6) consecutive posi-
tions according to the instruction manual for the spe-
cific instrument.
Measurements:
7. Reagents and buffers are loaded onto the instru-
ment, which is programmed as required to give
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Table 10 Human IgG – calculated and measured values of the Samples – day 1.
Day 1 Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Control
X-values 1.0000 0.8984 0.7974 0.5921 0.3977 0.2470 9.0169
Y-values 1.2024 1.0926 0.9580 0.7098 0.4747 0.3056 1.0164
Table 9 Human IgG – measured values obtained by interpolation.
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Control
Run  1
Repl. 1, % 10.9300 9.9900 8.6700 6.3800 4.3100 2.7800 9.2600
Repl. 2, % 10.8100 9.9000 8.6400 6.5600 4.4000 2.7700 9.0500
Mean, % 10.8700 9.9450 8.6550 6.4700 4.3550 2.7750 9.1550
Run  2
Repl. 1, % 11.0000 9.9900 8.8800 6.3800 4.1900 2.8100 9.2700
Repl. 2, % 10.9100 9.9600 8.7600 6.4900 4.3100 2.8200 9.0200
Mean, % 10.9550 9.9750 8.8200 6.4350 4.2500 2.8150 9.1450
Run  3
Repl. 1, % 11.0500 10.0200 8.8000 6.4700 4.3600 2.7700 9.1100
Repl. 2, % 11.0800 9.9100 8.6600 6.5500 4.4000 2.7700 9.2800
Mean, % 11.0650 9.9650 8.7300 6.2350 4.3800 2.7700 9.1950
Average, % 10.9633 9.9617 8.7350 6.4717 4.3283 2.7867 9.1650
the best possible determination of the specific
protein (see refs. 3, 8).
8. The instrument is started, and 3 complete runs
(calibrations and determinations of samples and
controls) are carried out. This corresponds to
1 day in the value assignment procedure. The fol-
lowing data are printed: Parameter settings and
for each calibration: Calibration data, sample and
control data and calibration curve plot.
9. The measured average values in % represent the
Y-values for 1 day (Table 9). Since the values are
obtained by automatic interpolation on the cali-
bration curve, these values are expressed as rel-
ative concentration factors wFR(1–6)x of the
Reference Material. To make them comparable
with the X-values, the following calculation is
made (e.g., for Sample 1):




The actual data used are found in Tables 9, 6 and
2, respectively.
The Control Value is calculated in the following
way:
Day 15Average (Control)/Relative Concentration
in %59.1650/9.016951.0164
The actual data are from Tables 9 and 5, respectively.
10. The calibration, the dilutions and the measure-
ments of the Samples for 1 day are now com-
pleted and the results can be listed as (Table 10):
a. the X-values of the Samples wFT2(1–6)x rep-
resenting the calculated relative concentra-
tion values as obtained by dilutions of the
Target Material into 6 Samples and
b. the Y-values of the Samples wFR(1–6)x repre-
senting the measured relative concentration
values as obtained by interpolation of the sig-
nals of the 6 Samples on the calibration
curve.
11. The control sample serving as a curve control of
the calibration curve is expected to be 1.000 and
is found to be 1.0164, which is very good, indi-
cating that the experimental setup has worked
satisfactorily.
12. If the Reference Material and the Target Material
show true Proportionality, a single straight line
should be obtained, if the Y-values are plotted
against the X-values. Since the X-values are cal-
culated based on weighing (with 4 decimals), the
uncertainty can be regarded as negligible com-
pared to the uncertainty of the interpolated val-
ues measured in the immunochemical method
(turbidimetry). It is therefore recommended to
perform a least squares linear regression anal-
ysis, where:
Y5aHbX
As seen from Table 11, a zero intercept for the
regression is definitely within the confidence interval,
permitting a new calculation, in which the regression
line is forced through zero (Figure 1, Table 12).
13. According to (3) the slope is equal to the ratio of
the concentrations of IgG in the two materials:
b5C /CT R
Since the slope has been calculated from the linear
regression analysis, the unknown concentration CT of
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Figure 1 Direct value assignment of human IgG.
The measured relative concentration values of the samples
plotted against the calculated relative concentration values
of the samples.
Table 12 Human IgG – least squares linear regression







IgG in the Target Material can now easily be found
as:
C 5C $bT R
where CR is the corrected concentration value of IgG
after reconstitution according to Table 1. So, for 1 day
the following concentration of IgG has been found:
C 59.68 g/L$1.005025$1.2057511.7298 g/LT
14. To accomplish a full Direct Value Assignment,
the setup for 1 day is carried out a total of 4
times, preferably on 4 different days but at least
on 2 different days with a completely new start
from reconstitution and dilution every time. It is
also mandatory to use the same instrument, the
same operator and the same lot numbers of all
reagents every time.
15. An example of a full value assignment is shown
in Figure 2. The final concentration value for IgG
in the Target Material was found to be:
"CT511.69 0.12 g/L
with a CV51.1%
16. The IgG concentration in the Reference Material
CRM 470 (ERM-DA 470) is stated as 9.68 g/L with
an uncertainty of 0.10 g/L.
The IgG concentration in the Target Material was
found to be 11.69 g/L with an uncertainty of
0.0617 g/L, as shown in Figure 2.
The total weighted uncertainty is found to be:
2 2Uncertainty 5tw(U /C ) H(U /C ) x$CTotal R R Transfer T T
2 2U 5tw(0.10/9.68) H(0.0617/11.69) x$11.69Total
50.1356 g/L
From this, it can be seen that UTotal is mostly
influenced by the uncertainty of the Reference
Material and very little by the uncertainty of the
value transfer.
Acceptance criteria
After several years of experience, the following gen-
eral rejection and acceptance criteria for single data
points, data series or whole data sets are now used.
A very important criterion is visual inspection. By
plotting the data from each day in different colors,
precision and trueness can easily be detected and
separated:
Rejection:
1. The protocol was not followed.
2. All data points are outside the calibration range.
Acceptance:
1. The zero intercept is accepted if the numeric value
of the intercept "4=std. dev. -0.01.
2. The mean control value is within 1.0000"0.05.
3. All results are within the overall mean "3=SD.
Alternative protocol for closed measuring
systems
In closed measuring systems, it is not possible to use
the Reference Material as the calibrator and directly
assay the Target Material as samples. In these sys-
tems, the manufacturer’s dedicated calibrator must be
used as the calibrator and both the Reference Material
and the Target Material assayed as samples. In a
closed system, the preparation and dilutions of the
Reference and Target Materials are made in essen-
tially the same fashion as discussed above, except
that all dilutions must have concentrations within the
linear portion of the required calibration curve. This
requires predetermination of the approximate con-
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Figure 2 Direct value assignment of human IgG.
Final statistics, plot and results of a full value assignment as they are presented in the Excel spreadsheet.
centrations of the two materials to be compared. The
number of assays and replicates is the same as
above.
The data in this case will therefore give two regres-
sion lines, with the dilutions of each material plotted
against the concentrations as determined against the
manufacturer’s calibration curve. Because the X-values
for both materials are calculated based on weighing
(with 4 decimals) the uncertainty can be regarded as
negligible. Therefore, a least squares linear regression
analysis – not a Deming regression – should be used.
If there are no matrix effect problems among the
three materials, and the calibration curve has been
properly determined, both lines should give zero
intercepts within the limits discussed above. If the
slopes of the two regression lines are then calculated
without an intercept, the ratio of these two slopes will
give the ratio of the concentrations of the analyte in
the two materials:
C 5C $(b /b )T R T R
However, if the two regressions are linear but both
show a similar, non-zero intercept, the ratio of their
concentrations can be determined, but it should be
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Figure 3 Value assignment of human IgG in closed meas-
uring system.
Table 13 Human IgG – least squares linear regression – day
1.
SD
Slope (Target) 9.0930 0.0597
Intercept (Target) 0.0223 0.0392
Slope (Reference) 9.6360 0.0780
Intercept (Reference) 0.0370 0.0511
Table 14 Human IgG – least squares linear regression
forced through zero – day 1.
SD
Slope (Target) 9.1246 0.0208
Intercept (Target) 0.0000
Slope (Reference) 9.6886 0.0274
Intercept (Reference) 0.0000
noted that the manufacturer’s calibrator shows a
matrix difference, and/or the calibration equation is
incorrect. If the same calibration method is to be used
for assaying patient samples accurately, it is essential
that the reason for the non-zero intercepts be deter-
mined and the problem be corrected. Otherwise, the
results can be correct at only one point of the calibra-
tion curve.
The graph in Figure 3 shows the actual regression
lines for 1 day in a recent value assignment in a
closed measuring system using CRM 470 as the Ref-
erence Material.
In Table 13, the least squares regressions give the
values for the Target Material and the Reference
Material.
As seen from Table 13, both intercepts are not sig-
nificantly different from zero, permitting a new cal-
culation, in which the regression lines are forced
through zero (Table 14).
The concentration in the Target Material is then cal-
culated as:
C 5(9.1246/9.6886)$9.68 g/L$Corr. FactorT
59.12 g/L
where 9.68 g/L is the IgG concentration assigned
to CRM 470 corrected with the reconstitution
factor, which in this case was the same for both
materials.
Discussion
When increasing amounts of an antigen is added to
a constant amount of the corresponding antibody, a
continuous increasing signal (due to the immune
complexes) is formed. However, as demonstrated by
Heidelberger and Kendall in 1935 (9), this reaction
does not form a straight line but a curved curve,
which passes through an optimum reflecting the max-
imum binding capacity of the antibody. This is a
unique and special feature of all immunochemical
reactions taking place in solution. For immunoturbi-
dimetry and immunonephelometry, the most reliable
measurements are obtained on the left-hand side of
the immunoprecipitation curve, i.e., in the antibody
excess zone.
The value assignment protocol is designed to take
advantage of all these conditions. The setup is made
in such a way that the reaction curve of the 6 different
dilutions of the Reference Material is directly com-
pared to the reaction kinetics of the 6 different dilu-
tions of the Target Material. If they behave in the
same way when reacting with the corresponding anti-
body, i.e., they show the same non-linear reaction
kinetics, they are considered to be proportional (show
proportionality), and a linear relationship passing
through zero can be established when plotting the
measured relative concentration values of the sam-
ples against the calculated relative concentration val-
ues of the same samples. The slope of this regression
line will reflect the ratio of the analyte concentration
in the two materials.
The exact same principles should be considered,
when a patient sample is assayed and interpolated on
a calibration curve. Only if the two materials show
proportionality can a reliable result be obtained over
the calibration interval, i.e., the measuring range.
The reduction of uncertainty in clinical assays is
important for several reasons, including in particular
the improvement of patient care, both in diagnosing
diseases and in following changes due to disease and
treatment of the patient. In addition, the comparability
of values among assays is necessary for the devel-
opment of common reference intervals and for com-
parison of results among various population groups
(10).
The same reaction principles can be studied in a
closed measuring system provided the manufactur-
er’s calibrator behave in the same proportional way
as the Reference Material and the Target Material.
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The more theoretical principles of the value assign-
ment are outlined in our first paper (3). In this paper,
a more practical approach has been presented en-
abling manufacturers and others to conduct value
assignment in the most optimal way leading to more
reliable protein values of the calibrator and thus to
better and more comparable protein values for the
patient.
As discussed above, persisting among-manufactur-
er variation in protein assays may result from several
factors, but the only one of these that can be readily
addressed is the assignment of values to the materi-
als used for calibrators and controls. The protocol pre-
sented here is designed to perform the assignment of
values to both master calibrators and commercial, or
‘‘working,’’ calibrators with as little uncertainty as is
practically possible.
The protocol requires little if any effort over and
above methods in common use by manufacturers and
has been shown to result in a significant reduction in
uncertainty of assigned values. We strongly encour-
age its use for all serum protein value assignments.
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